NasdaqGM - Nasdaq Real Time Price USD
Sage Therapeutics, Inc. (SAGE)
At close: October 22 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-373,654.00
-540,585.00
-460,036.00
-378,182.00
664,280.00
--
Investing Cash Flow
341,503.00
442,913.00
325,433.00
-1,002,448.00
442,684.00
--
Financing Cash Flow
12,136.00
6,027.00
3,070.00
13,334.00
426,762.00
--
End Cash Position
102,733.00
72,324.00
163,969.00
295,502.00
1,662,798.00
--
Capital Expenditure
--
-553.00
-937.00
-372.00
-345.00
--
Issuance of Capital Stock
--
--
--
--
417,500.00
561,277.00
Free Cash Flow
-373,870.00
-541,138.00
-460,973.00
-378,554.00
663,935.00
--
12/31/2019 - 7/18/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACAD ACADIA Pharmaceuticals Inc.
14.52
-1.63%
CYTK Cytokinetics, Incorporated
54.94
+2.10%
AGIO Agios Pharmaceuticals, Inc.
45.38
-0.61%
APLS Apellis Pharmaceuticals, Inc.
27.60
+2.68%
VYGR Voyager Therapeutics, Inc.
6.19
-19.19%
PRAX Praxis Precision Medicines, Inc.
72.25
-1.20%
ARVN Arvinas, Inc.
26.57
+3.14%
MRNS Marinus Pharmaceuticals, Inc.
1.7500
-3.85%
AMLX Amylyx Pharmaceuticals, Inc.
4.5300
-2.79%
URGN UroGen Pharma Ltd.
12.47
-0.40%